Works matching IS 07302312 AND DT 2023 AND VI 124 AND IP 2

Results: 13

How statin drugs affect exosomes?

Published in:

Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 171, doi. 10.1002/jcb.30363

By:

Sekhavati, Niloofar;
Noori, Elmira;
Abbasifard, Mitra;
Butler, Alexandra E.;
Sahebkar, Amirhossein

Publication type:

Article

Neutraligands of C5a can potentially occlude the interaction of C5a with the complement receptors C5aR1 and C5aR2.

Published in:

Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 266, doi. 10.1002/jcb.30360

By:

Das, Aurosikha;
Ghosh, Manaswini;
Gupta, Pulkit Kr.;
Rana, Soumendra

Publication type:

Article

Recent advance in mesenchymal stem cells therapy for atopic dermatitis.

Published in:

Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 181, doi. 10.1002/jcb.30365

By:

Najera, Jonathan;
Hao, Jijun

Publication type:

Article

Induced expression of miR‐1250‐5p exerts tumor suppressive role in triple‐negative breast cancer cells.

Published in:

Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 282, doi. 10.1002/jcb.30362

By:

Shuaib, Mohd;
Kumar, Shashank

Publication type:

Article

The epigenetic regulator BRD4 is required for myofibroblast differentiation of knee fibroblasts.

Published in:

Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 320, doi. 10.1002/jcb.30368

By:

Dudakovic, Amel;
Bayram, Banu;
Bettencourt, Jacob W.;
Limberg, Afton K.;
Galvan, M. Lizeth;
Carrasco, Margarita E.;
Stans, Britta;
Thaler, Roman;
Morrey, Mark E.;
Sanchez‐Sotelo, Joaquin;
Berry, Daniel J.;
van Wijnen, Andre J.;
Abdel, Matthew P.

Publication type:

Article

The role of S477N mutation in the molecular behavior of SARS‐CoV‐2 spike protein: An in‐silico perspective.

Published in:

Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 308, doi. 10.1002/jcb.30367

By:

Mondeali, Mozhgan;
Etemadi, Ali;
Barkhordari, Khabat;
Mobini Kesheh, Mina;
Shavandi, Sara;
Bahavar, Atefeh;
Tabatabaie, Fatemeh Hosseini;
Mahmoudi Gomari, Mohammad;
Modarressi, Mohammad H.

Publication type:

Article

Inhibition of sPLA2 enzyme activity by cell‐permeable antioxidant EUK‐8 and downregulation of p38, Akt, and p65 signals induced by sPLA2 in inflammatory mouse paw edema model.

Published in:

Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 294, doi. 10.1002/jcb.30366

By:

Jayachandra, Krishnegowda;
Gowda, M. D. Milan;
Rudresha, Gotravalli V.;
Manjuprasanna, Vaddarahally N.;
Urs, Amog P.;
Nandana, Manuganahally Basavarajappa;
Bharatha, Madeva;
Jameel, Noor Mohamed;
Vishwanath, Bannikuppe S.

Publication type:

Article

Effects of the pathological E200K mutation on human prion protein: A computational screening and molecular dynamics approach.

Published in:

Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 254, doi. 10.1002/jcb.30359

By:

Gharemirshamloo, Fatemeh Rahimi;
Majumder, Ranabir;
Kumar S., Udhaya;
Doss C., George Priya;
Bamdad, Kourosh;
Frootan, Fateme;
Un, Cemal

Publication type:

Article

Discovery of octahydropyrrolo [3,2‐b] pyridin derivative as a highly selective Type I inhibitor of FGFR3 over VEGFR2 by high‐throughput virtual screening.

Published in:

Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 221, doi. 10.1002/jcb.30357

By:

Wang, Xin;
Ye, Cheng‐hao;
Li, En‐min;
Xu, Li‐yan;
Lin, Wang‐qiang;
Chen, Guang‐hui

Publication type:

Article

Differential gene expression analysis of RAGE‐S100A6 complex for target selection and the design of novel inhibitors for anticancer drug discovery.

Published in:

Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 205, doi. 10.1002/jcb.30356

By:

Faruqui, Tabrez;
Singh, Garima;
Khan, Salman;
Khan, Mohd Sajid;
Akhter, Yusuf

Publication type:

Article

An integrated investigation of structural and pathway alteration caused by PIK3CA and TP53 mutations identified in cfDNA of metastatic breast cancer.

Published in:

Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 188, doi. 10.1002/jcb.30354

By:

R., Hephzibah Cathryn;
Kumar S., Udhaya;
R., Gnanasambandan;
Naayanan, P. Jeyaprakash;
Sathiyarajeswaren, P.;
Devi, M. S. Shree;
K., Satish Srinivas;
Doss C., George Priya

Publication type:

Article

Issue Information.

Published in:: Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 169, doi. 10.1002/jcb.30282
Publication type:: Article

IGF2BP2 enhances LincRNA01116 stability via m6A: A potential biomarker and therapeutic target for patients with pre‐eclampsia.

Published in:

Journal of Cellular Biochemistry, 2023, v. 124, n. 2, p. 239, doi. 10.1002/jcb.30358

By:

Zhang, Tingting;
Tang, Xiaotong;
Zhu, Yuanyuan;
Wang, Cong;
Jiang, Ziyan;
Yang, Nana;
Wang, Tianjun;
Shu, Lijun;
Xu, Yetao;
Sun, Lizhou

Publication type:

Article

Works matching IS 07302312 AND DT 2023 AND VI 124 AND IP 2

How statin drugs affect exosomes?

Neutraligands of C5a can potentially occlude the interaction of C5a with the complement receptors C5aR1 and C5aR2.

Recent advance in mesenchymal stem cells therapy for atopic dermatitis.

Induced expression of miR‐1250‐5p exerts tumor suppressive role in triple‐negative breast cancer cells.

The epigenetic regulator BRD4 is required for myofibroblast differentiation of knee fibroblasts.

The role of S477N mutation in the molecular behavior of SARS‐CoV‐2 spike protein: An in‐silico perspective.

Inhibition of sPLA<sub>2</sub> enzyme activity by cell‐permeable antioxidant EUK‐8 and downregulation of p38, Akt, and p65 signals induced by sPLA<sub>2</sub> in inflammatory mouse paw edema model.

Effects of the pathological E200K mutation on human prion protein: A computational screening and molecular dynamics approach.

Discovery of octahydropyrrolo [3,2‐b] pyridin derivative as a highly selective Type I inhibitor of FGFR3 over VEGFR2 by high‐throughput virtual screening.

Differential gene expression analysis of RAGE‐S100A6 complex for target selection and the design of novel inhibitors for anticancer drug discovery.

An integrated investigation of structural and pathway alteration caused by PIK3CA and TP53 mutations identified in cfDNA of metastatic breast cancer.

Issue Information.

IGF2BP2 enhances LincRNA01116 stability via m<sup>6</sup>A: A potential biomarker and therapeutic target for patients with pre‐eclampsia.